Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome

This study has been completed.
Sponsor:
Collaborators:
River Plate Biotechnology, Inc.
Rx Development Resources, LLC
Information provided by:
Lantibio
ClinicalTrials.gov Identifier:
NCT00599716
First received: January 11, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)